Shanghai HeartCare Medical Technology (HKSE:06609) Mohanram G-Score: 4 (As of Dec. 2025) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06609 Shanghai HeartCare Medical Technology Corp Ltd HKSE:06609
78 GF Score
Price HK$48.24
GF Value HK$54.80
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Shanghai HeartCare Medical Technology Mohanram G-Score?

Shanghai HeartCare Medical Technology HKSE:06609 -4.29% 78 Mohanram G-Score is 4 as of Dec. 2025, which is at its 10-year median of 4.00. GuruFocus rates HKSE:06609 with a GF Score™ of 78/100 and a GF Value™ of HK$54.80 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Mohanram G-Score is a financial indicator developed by professor Partha Mohanram to help investors find the best investment opportunities in the growth stocks. Companies have higher G-score tends to generate higher return. According to his study, the best growth stocks that have a G-Score greater than 6 tend to beat the market, while those with a G-Score lower than 1 tend to have negative absolute returns.

Thus, the zones of discrimination were as such:

Good or high score = 6, 7, 8
Bad or low score = 0, 1

Shanghai HeartCare Medical Technology has an G-score of 4.

The historical rank and industry rank for Shanghai HeartCare Medical Technology's Mohanram G-Score or its related term are showing as below:

HKSE:06609' s Mohanram G-Score Range Over the Past 10 Years
Min: 4   Med: 4   Max: 4
Current: 4

During the past 7 years, the highest Piotroski G-score of Shanghai HeartCare Medical Technology was 4. The lowest was 4. And the median was 4.

Shanghai HeartCare Medical Technology  (HKSE:06609) Mohanram G-Score Explanation

Partha Mohanram is the John H. Watson Chair in Value Investing at Rotman and the Acting Vice-Dean of Research Strategy and Resources.

In 2000, he wrote a research paper called "Separating Winners from Losers Among Low Book-to-Market Stocks Using Financial Statement Analysis".

This paper tests whether a strategy based on financial statement analysis of low book-to-market (growth) stocks is successful in differentiating between winners and losers in terms of future stock performance. Based on the research, a strategy based on buying high G-score (6, 7 or 8) firms and shorting low G-score (0 or 1) firms consistently earns significant excess returns. Further, the results do not support a risk based explanation for the book-to-market effect as the strategy returns positive returns in all years, and firms that ex-ante appear less risky have better future returns.

To conclude, one can use a modified fundamental analysis strategy (G-score) to identify mispricing and earn substantial abnormal returns.


Shanghai HeartCare Medical Technology Mohanram G-Score Related Terms


Shanghai HeartCare Medical Technology Mohanram G-Score Historical Data

* Premium members only.

The historical data trend for Shanghai HeartCare Medical Technology's Mohanram G-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai HeartCare Medical Technology Mohanram G-Score Chart

Shanghai HeartCare Medical Technology Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Mohanram G-Score
Get a 7-Day Free Trial N/A N/A N/A N/A 4.00

Shanghai HeartCare Medical Technology Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Mohanram G-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A 4.00

HKSE:06609 vs ABT, SYK, MDT: Mohanram G-Score Comparison

For the Medical Devices subindustry, Shanghai HeartCare Medical Technology's Mohanram G-Score, along with its competitors' market caps and Mohanram G-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai HeartCare Medical Technology Mohanram G-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai HeartCare Medical Technology's Mohanram G-Score distribution charts can be found below:

* The bar in red indicates where Shanghai HeartCare Medical Technology's Mohanram G-Score falls into.


HKSE:06609
78GF Score
Shanghai HeartCare Medical Technology Corp Ltd HKSE:06609
Mohanram G-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai HeartCare Medical Technology Mohanram G-Score Calculation

The calculation of the Mohanram G-score consists of eight criteria. Assign one point for each criterion met, then add up all the points to get the G-Score.

Profitability

Question 1. Return on Assets (ROA)

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. It measures how well a company uses its asset to generate earnings.

Score 1 if ROA > ROA Industry Median, 0 otherwise.

Question 2. Cash ROA

Cash ROA equals to Cash Flow from Operations divided by average Total Assets. It measures how well a company uses its asset to generate cash.

Score 1 if Cash ROA > Cash ROA Industry Median, 0 otherwise.

Question 3. CFO and Net Income

Score 1 if CFO > Net Income, 0 otherwise.

Earnings Predictability

Question 4. Earnings Variability

Earnings Variability is measured as the variance of a firm's ROA in the past five years.

Score 1 if Earnings Variability < Earnings Variability Industry Median, 0 otherwise.

Question 5. Sales Growth Variability

Sales Growth Variability is measured as the 5-year variance in sales growth.

Score 1 if Sales Growth Variability < Sales Growth Variability Industry Median, 0 otherwise.

Accounting Conservatism

Question 6. Research & Development Intensity

Research & Development Intensity is calcualted by Research & Development divided by the beginning Total Assets.

Score 1 if Research & Development Intensity > Research & Development Intensity Industry Median, 0 otherwise.

Question 7. CAPEX Intensity

CAPEX Intensity is calcualted by Capital Expenditure divided by the beginning Total Assets.

Score 1 if CAPEX Intensity > CAPEX Intensity Industry Median, 0 otherwise.

Question 8. Advertising Expenditure Intensity

Advertising Expenditure Intensity is calcualted by Advertising Expenditure divided by the beginning Total Assets. Note that Advertising Expenditure is not reported as a seperate line item for many companies, thus Selling, General, & Admin. Expense is used in this calculation.

Score 1 if Advertising Expenditure Intensity > Advertising Expenditure Intensity Industry Median, 0 otherwise.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note that all the Industry Median used for comparison in his original research, are substituted with Sector Median due to the limitation of data within certain countries.

Good or high score = 6, 7, 8
Bad or low score = 0, 1

Shanghai HeartCare Medical Technology has an G-score of 4.

Frequently Asked Questions Learn more about Mohanram G-Score →
What does a Mohanram G-Score of 4 mean?
Shanghai HeartCare Medical Technology (HKSE:06609) has a Mohanram G-Score of 4 as of Dec. 2025. G-Score is a financial indicator developed by professor Partha Mohanram to help investors find the best investment opportunities in the growth stocks. View historical data on Shanghai HeartCare Medical Technology and its competitors. This is near median its historical median of 4.00. Over the past decade, Shanghai HeartCare Medical Technology's Mohanram G-Score has ranged from 4.00 to 4.00.
Is Shanghai HeartCare Medical Technology's Mohanram G-Score too high?
Shanghai HeartCare Medical Technology's current Mohanram G-Score of 4 is near median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 4.00. Overall, Shanghai HeartCare Medical Technology has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai HeartCare Medical Technology's Mohanram G-Score compare to ABT and SYK?
Shanghai HeartCare Medical Technology's Mohanram G-Score of 4 can be compared against companies in the Medical Devices & Instruments industry. Historically, Shanghai HeartCare Medical Technology's own Mohanram G-Score has ranged from 4.00 to 4.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Mohanram G-Score for a Medical Devices & Instruments company?
A good Mohanram G-Score depends on the Medical Devices & Instruments industry context. However, Mohanram G-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Mohanram G-Score mean?
A high Mohanram G-Score can signal that a stock is expensive relative to its fundamentals. G-Score is a financial indicator developed by professor Partha Mohanram to help investors find the best investment opportunities in the growth stocks. View historical data on Shanghai HeartCare Medical Technology and its competitors. Shanghai HeartCare Medical Technology's current Mohanram G-Score is 4, which is near median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai HeartCare Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai HeartCare Medical Technology (HKSE:06609) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$54.80, compared to a current price of HK$48.24 — trading 12% below its estimated fair value. The current Mohanram G-Score is 4, which is near median its 10-year median of 4.00. Shanghai HeartCare Medical Technology's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Mohanram G-Score calculated?
Mohanram G-Score is calculated from a company's financial statements. For Shanghai HeartCare Medical Technology (HKSE:06609), the current Mohanram G-Score is 4 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai HeartCare Medical Technology (HKSE:06609) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai HeartCare Medical Technology stock appears to be undervalued. The current stock price of HK$48.24 is trading 12% below its estimated GF Value™ of HK$54.80. GuruFocus considers Shanghai HeartCare Medical Technology to be Modestly Undervalued.

Key valuation signals for HKSE:06609:

  • Mohanram G-Score: 4 (near median its 10-year median of 4.00)
  • GF Value™: HK$54.80 vs. price of HK$48.24 (12% below fair value)
  • GF Score™: 78/100 with 2 warning signs

No single metric tells the full story. See the HKSE:06609 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai HeartCare Medical Technology Business Description

Address No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN
Shanghai HeartCare Medical Technology Corp Ltd is an neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. The company focuses on Research and development, manufacturing and commercialization to fulfill the unmet needs of clinicians and patients to redefine the standard of care, reduce mortality rate, and improve prognosis by continuously launching new medical devices. Geographically, the Group's majority revenue is derived from Chinese Mainland.
78GF Score

Get the complete analysis for HKSE:06609

Mohanram G-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$48.24
Price
HK$54.80
GF Value